Health News
Rx Combo Showed Promise for Ovarian Cancer
Ovarian cancer is the second most common cancer of the female reproductive organs. It's common for this cancer to return after initial treatment, but two therapies used together may help fight this cancer.
A Potential New Treatment for Bladder Cancer
Some cancers respond better to traditional treatments than others. Bladder cancer patients with a certain form of the disease have not always benefited from those treatments.
New data shows ProMark accurately predicts aggressive prostate cancer, pathology outcomes
Today, for the first time, Metamark presents results from the clinical validation study that showed ProMark™, the first and only proteomic-based imaging biopsy test, achieved its primary endpoint.
For Terminally Ill, Stopping Statins May Help
People with advanced life-limiting illnesses typically take an increasing number of medications. At this stage, however, some treatments, such as statins, may be unnecessary.
Indoor Tanning Devices Will Have New Warnings
Many young people strive for tan skin, but this quest could put them at a risk for cancer. Health officials announced changes to how indoor tanning devices are regulated.
Rx Lowered Risk of Early Menopause After Chemotherapy
Researchers are constantly looking for ways to ease the lasting side effects of chemotherapy, and they may have found help for younger breast cancer patients.
Hospitalization Risk Depended on Type of Chemotherapy Used
Chemotherapy for breast cancer comes with a long list of possible risks, including hospitalization, but not all chemotherapy regimens carry the same risk.
Lower Kidney Function Linked to Certain Cancers
The kidneys help rid the body of toxins. When the kidneys don’t function properly, it can open the door to other serious diseases, and cancer may be among them.
FDA to Require Warnings on Sunlamp Products
Today, the U.S. Food and Drug Administration issued a final order reclassifying sunlamp products and ultraviolet (UV) lamps intended for use in sunlamp products from low-risk (class I) to moderate-risk (class II) devices.
Circumcision Might Protect Against Prostate Cancer
While the only definite established risk factors for prostate cancer are African ancestry, advancing age, and a family history of the disease, not being circumcised may also pose a threat.